4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine

Vaccine. 2006 Nov 17;24(47-48):6867-74. doi: 10.1016/j.vaccine.2006.06.007. Epub 2006 Jun 22.

Abstract

We have constructed a recombinant fowlpox virus expressing HIV antigens and the costimulatory molecule 4-1BBL. When included in the boost, but not the prime of a poxvirus prime-boost strategy, 4-1BBL significantly enhanced the anti-HIV T cell response generated to this vaccination in BALB/c mice, as detected by ex vivo IFNgamma ELISPOT responses, intracellular cytokine staining to HIV Gag antigens, and enumeration of Gag-reactive CD8 T cells. 4-1BBL however, is not capable of modulating the CD4 T cell response, nor the antibody response to this vaccination strategy. Enhancement of the T cell response by 4-1BBL continues into the memory phase, as detected 2 months post vaccination. This data is the first to show modulation of the immune response to a viral vaccine by coexpression of 4-1BBL and supports this strategy as an exciting approach for enhancement of T cell memory in prime-boost vaccines.

MeSH terms

  • 4-1BB Ligand / biosynthesis*
  • 4-1BB Ligand / genetics
  • 4-1BB Ligand / physiology*
  • Animals
  • Antibody Formation / immunology
  • Antibody Specificity
  • CD8-Positive T-Lymphocytes / immunology*
  • Epitopes / immunology
  • Female
  • Flow Cytometry
  • Fowlpox virus / immunology*
  • HIV / immunology*
  • HIV Antigens / immunology*
  • Immunization, Secondary*
  • Immunologic Memory / genetics
  • Immunologic Memory / physiology*
  • Mice
  • Mice, Inbred BALB C
  • Vaccines, Synthetic / immunology

Substances

  • 4-1BB Ligand
  • Epitopes
  • HIV Antigens
  • Vaccines, Synthetic